Diethylene glycol (DEG) and ethylene glycol (EG) are toxic industrial liquids that look and feel very similar to glycerine. Over several decades, glycerine and other syrup ingredients contaminated with or substituted by DEG have caused mass poisonings through medicines. As a result, pharmacopoeia glycerine is specifically tested for both glycols, and regulators expect manufacturers to test every lot. This article explains why and what it means for buyers.
Why glycerine is a risk
Glycerine is clear, colourless, sweet and viscous. DEG and EG share enough of those properties that substitution or contamination cannot be spotted by eye, smell or simple density checks. Glycerine is used in cough syrups, oral solutions, toothpaste and many personal care products, so a contaminated lot can reach large numbers of people, including children.
What the standards and regulators require
- Pharmacopoeia monographs. The USP glycerin monograph includes an identification and limit test for DEG and EG by gas chromatography. A lot that fails is not USP grade, whatever its assay.
- US FDA guidance. In 2023 the FDA issued guidance on testing glycerin, propylene glycol, sorbitol solution and other high-risk drug components for DEG and EG, replacing its earlier 2007 glycerin guidance. It recommends identity testing, including the DEG and EG test, on each container of each lot before use in drug manufacture.
- Supply chain records. The same guidance stresses knowing the full supply chain, including the original manufacturer, because many incidents involved relabelled or repackaged material.
Other regions apply similar requirements through their own pharmacopoeias and medicines regulators. Even where a product is a cosmetic or detergent rather than a medicine, responsible manufacturers increasingly apply the same check.
How the test works in practice
A sample is analysed by gas chromatography and compared with reference standards for DEG and EG. The method is routine for a competent laboratory and fast enough to run on incoming lots. What matters is that the sample genuinely comes from the container being used, which is why regulators focus on testing each container rather than a single composite sample for drug use.
| Grade | DEG/EG testing | Typical use |
|---|---|---|
| USP / Ph. Eur. / BP | Required by the monograph; regulators expect per-container testing for drug use | Medicines, oral care, cosmetics |
| Food grade | Usually tested; confirm with supplier | Food and beverage processing |
| Technical grade | Not guaranteed | Resins, industrial uses |
Why traders and repackers are in focus
Glycerine often passes through several hands between refinery and user: a producer, a trader, a repacker and a local distributor. Each transfer is a point where material could be mixed, relabelled or put into a dirty container. Regulators therefore expect manufacturers to know who made the glycerine, not only who sold it, and to treat bulk material that has been repacked with particular care.
Practical protections for buyers
- Buy pharmacopoeia grade for any product that people ingest or apply to skin, and make sure the CoA names the monograph and edition.
- Ask for the name of the original manufacturer as well as the trader.
- Check that the CoA includes a DEG and EG result, not just an assay.
- Keep containers sealed and labelled from receipt to use, so the identity chain is not broken in your own warehouse.
- Test on receipt if you make medicines, and consider doing so for oral care and children's products as well.
Purity alone does not prove glycerine is safe for pharmaceutical use; a DEG and EG test on each lot does.
What to request from your supplier
Specify the grade (for example USP), require a CoA showing DEG and EG results for each lot, and ask for manufacturer traceability. Third-party inspection and sampling at loading can add assurance for large orders. Nuroil provides a CoA with every delivery and arranges third-party inspection on request; discuss your requirements through contact us.
